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Abstract
Purpose The aim of this study was to investigate the
predictive potential of pre-operative regional cerebral blood
flow (rCBF) in the pre-supplementary motor area (pre-SMA)
and clinical factors in Parkinson’s disease (PD) patients
treated with subthalamic nucleus (STN) stimulation.
Methods Ten patients underwent rCBF SPECT and motor
Unified Parkinson’s Disease Rating Scale (UPDRS) pre-
and post-operatively during stimulation at 5 and 42 months.
Statistical parametric mapping (SPM) was used to extract
rCBF values in the pre-SMA because it is related with
motor improvement. Post-operative outcomes included
motor response to stimulation and percent improvement in
UPDRS. Pre-operative predictors were explored by corre-
lation test, linear regression and multivariate analyses.
Results Higher pre-operative rCBF in the pre-SMA and
younger age were associated with favourable outcomes at 5
and 42 months. Pre-operative rCBF results were signifi-
cantly associated with baseline clinical factors.
Conclusion This study shows that PD patients with
younger age have higher rCBF values in the pre-SMA
and better outcome, thus giving the rationale to the
hypothesis that STN stimulation could be considered early
in the course of disease.
Keywords Parkinson’s disease . Subthalamic stimulation .
Predictive potential . rCBF. Pre-SMA
Introduction
High-frequency deep brain stimulation (DBS) of the
subthalamic nucleus (STN) has gained widespread accep-
tance and is now regarded by many as the surgical
treatment of choice for patients with an advanced form of
Parkinson’s disease (PD) who meet strict criteria for
treatment of this type [1]. According to general recom-
mendations [2], these include age under 70 years at time of
surgery, a levodopa-responsive form of PD characterized by
disabling on-off phenomena and levodopa-induced dyski-
nesia, the absence of abnormal cerebral MRI findings,
dementia and psychiatric disorders. Therefore, the mean
delay before STN DBS has been shown to be currently
14 years after diagnosis [3], when medical treatment no
longer controls motor symptoms and quality of life is
already severely impaired [4].
In order to prevent psychological degradation and
maintain quality of life, especially in young patients facing
a long course of disease, it has been suggested that
neurosurgery could be performed earlier after the diagnosis
of PD [4–6]. Indeed, the majority of clinical studies have
shown that outcomes from STN DBS tend to be better in
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patients with younger age at time of surgery [4–10].
Moreover, a favourable outcome from DBS has been also
observed in patients with shorter disease duration, lower
motor Unified Parkinson’s Disease Rating Scale (UPDRS)
and motor symptoms responsive to L-dopa [7–12]. However,
there is no general consensus as yet on the use of STN
DBS in younger parkinsonian patients. Indeed, results of
two clinical studies failed to detect statistically significant
correlations between age at time of operation and post-
operative results [13, 14]. Besides, prediction of greatest
beneficial response to STN DBS in younger patients has
been observed mainly in the short term [4, 5, 7–9], and the
mechanisms underlying the influence of age on post-
operative outcome have not been fully clarified [15].
Positron emission tomography studies and covariance
analyses applied to single photon emission computed
tomography (SPECT) imaging data have opened up the
challenging opportunity to study the neural networks
underlying recovery of motor function related to STN
DBS. Results of functional imaging studies comparing the
stimulators on with the stimulators off conditions at rest
[16] or during motor tasks [17, 18] have shown that
improvement of motor performance is mainly related to
regional cerebral blood flow (rCBF) increases in the rostral
part of the pre-supplementary motor area (pre-SMA).
Similarly, several follow-up studies performed in the on
and off stimulation conditions have highlighted that this
cortical area plays a crucial role in recovery of motor
function during long-term treatment with STN DBS [19,
20]. In line with results of these studies, it has been
suggested that a careful evaluation of the correlation
between pre-operative functional parameters in strategical
regions of the brain such as the rCBF in the pre-SMA and
post-operative clinical outcome measures could provide
important information concerning a possible role of such
parameters in predicting outcomes from DBS [15, 19].
However, no studies have been made to investigate the role
of pre-operative functional imaging with respect to pre-
dictors of response to surgery [15].
The main aim of the present study was to investigate
the predictive potential of pre-operative rCBF in the pre-
SMA in PD patients treated with bilateral long-term STN
DBS in order to identify characteristics of the candidate
who may receive the greatest benefit from surgery.
Along with rCBF in the pre-SMA, the predictive role
of several pre-operative clinical factors including age at
time of surgery was also investigated. The predictive
potential was evaluated at 5 and 42 months after DBS
implants to test whether prediction of clinical improve-
ment in the short term was confirmed in the long term.
Relationships between pre- and post-operative clinical
and functional imaging data were also analysed to
provide novel insights into the mechanisms underlying
the influence of the function in the pre-SMA and age on
post-operative outcomes in this population.
Materials and methods
Patient selection and surgical procedure
The clinical characteristics of PD patients have been
described previously [19]. Ten consecutive patients with
medically intractable PD who underwent DBS implantation
in 1999 at our hospital were included in the study (4
women, 6 men, mean age: 64±4 years, mean disease
duration: 15±5 years, range of disease duration: 6–
22 years). All patients were right-handed. The side
prevalence of motor symptoms was left in one patient,
bilateral in two patients and right in seven patients. Bilateral
implantation of electrodes in the STN was performed only
in the presence of clinically diagnosed idiopathic PD as
defined by the UK Parkinson’s Disease Society Brain Bank
[21], disabling motor fluctuations despite all drug therapies,
an age of <70 years, a response to levodopa greater than
30%, normal cerebral MRI findings, the absence of
significant cognitive impairment as ascertained by means
of the Mini-Mental State Examination with a cut-off value
of 24/30 (mean value ± SD=27.8±1.4), major ongoing
psychiatric illness and dopaminergic treatment-induced
psychosis in the 6-month period preceding surgery. The
exclusion criteria were neurological signs suggestive of
secondary forms of parkinsonism and the presence of other
significant medical illnesses [2]. The procedure for bilateral
implantation of STN electrodes conformed to the previously
published procedure [22, 23]. There were no serious
complications due to surgery. In all patients continuous
monopolar stimulation was applied bilaterally. Stimulator
settings remained substantially stable during the course of
the study. The mean values of voltage intensity, frequency
stimulation and the pulse width used at 5 and 42 months
after surgery were as follows: 2.8±0.4 V (range: 2.3–3.7 V)
and 2.9±0.5 V (range: 2–3.7 V); 140±12 Hz (range: 135–
185 Hz) and 144±16 Hz (range: 130–185 Hz); 85±34.5 μs
(range: 60–210 μs) and 93±44 μs (range: 60–210 μs).
Written informed consent was obtained from all subjects
according to the Declaration of Helsinki. The Ethics
Committee of our institution approved the study.
Assessment of pre- and post-operative clinical parameters
Clinical evaluation included the motor UPDRS [19].
Evaluation was performed pre-operatively within 1 week
prior to the surgical procedure and post-operatively at 5 and
42 months. Pre-operatively the patients were evaluated in a
defined “medication off state” without intake of PD
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medication for at least >12 h and “medication on state”
when the best clinical response was obtained following
their usual dose of L-dopa. At the time of surgery, the
mean UPDRS motor stimulation on score was 64±4 and
mean baseline percent improvement in UPDRS motor
score (calculated as: L-dopa responsiveness = medication
off scores – medication on scores/medication off scores ×
100) was 35±3. The mean administered dose of L-dopa
before DBS was 1.440±465 mg/day. Post-operatively all
patients were tested in the stimulation on and medication
off condition. The mean motor UPDRS at 5 and 42 months
after DBS were 48±12 and 41±9, respectively. The mean
improvements in UPDRS motor scores from the pre-
to the post-operative conditions at 5 and 42 months
(calculated as medication off scores at baseline –
medication off and stimulation on scores at optimized
follow-up/medication off scores at baseline × 100) were
26 and 36%, respectively. The mean administered dose
of L-dopa decreased at a value of 897±189 and 655±155
at 5 and 42 months, respectively.
Assessment of pre- and post-operative rCBF
in the pre-SMA
Along with clinical evaluation, PD patients underwent
rCBF three times, once pre-operatively in the off medica-
tion state and two times post-operatively, i.e. in the
stimulation on and medication off condition at 5 and
42 months, respectively [19]. In summary, SPECT images
were acquired 30 min after an intravenous dose (740 MBq
in all scanning conditions) of 99mTc-ethyl cysteinate dimer
(ECD) (bicisate, Neurolite, DuPont Merck Pharmaceutical
Co., Billerica, MA, USA) using a triple-head rotating
gamma camera (PRISM 3000, Picker International Inc.,
Cleveland, OH, USA) equipped with ultra-high-resolution
fan beam collimators.
Images were analysed for regionally specific effects
using statistical parametric mapping (SPM) developed at
the Wellcome Functional Imaging Laboratory (http://www.
fil.ion.ucl.ac.uk./spm/) implemented in MATLAB, version
5.3 (The MathWorks, Inc., Natick, MA, USA) [24]. After
conversion from Interfile into Analyze format using the
ImageJ software (http://rsb.info.nih.gov./ij/), all images
were spatially realigned to the first one of the series in
order to compensate for position changes. All brain images
were then spatially transformed into the standard stereotactic
space. The default spatial normalization procedure
employed was based on a bilinear interpolation method,
involving a 12-parameter linear affine transformation and
a non-linear three-dimensional deformation to match
each scan to a generic SPECT template. A resulting
voxel size of 2×2×2 mm was used. The normalized
images were smoothed with an isotropic 13-mm kernel.
A covariance analysis was performed to extract regions
whose increases in rCBF from the pre- to the post-operative
conditions at 5 and 42 months correlated significantly with
improvement in motor function. To assess specific effects
of this covariate on rCBF, individual UPDRS motor scores
during each scanning condition were introduced into the
design paradigm. Importantly, the effect of age on rCBF
was also taken into account by introducing this factor as
confounding covariate in the study design. After specifying
the appropriate design matrix, image intensity was normal-
ized between subjects to prevent inter-subject variability in
tracer uptake from masking regional changes. To this end,
the proportional scaling technique was performed. Global
blood flow was normalized by scaling across the entire data
set to a grand mean of 50 ml/100 ml per minute
(normalization by scaling to average whole-brain activity).
The grey matter threshold was set to the default value of
0.8. These analyses produced a t statistic for each voxel,
which constituted the statistical parametric map SPM{t}.
The SPM{t} map was then transformed to the unit normal
distribution to give a Gaussian field or SPM{Z}. The level
of significance of areas of rCBF changes was assessed by
the spatial extent (k) and peak height (u) of their foci using
estimations based on the theory of Gaussian fields. It is
noteworthy that for the sake of brevity, relative perfusion
increases or decreases as compared to the mean brain
uptake were conventionally referred to as “rCBF” without
meaning that these values really express rCBF; rather they
reflect a regional deviation from the mean brain uptake of
99mTc-ECD. Results of statistical analysis showed that a
significant relationship between individual motor UPDRS
scores and rCBF (p<0.0001, z-score = 3.68) was present in
the right pre-SMA (x=6, y=4, z=62; spatial extent of
cluster = 141 voxels) [19].
In the present analysis, individual rCBF values in the
pre-SMA for each scanning condition were extracted using
exactly the irregular volume of interest (VOI) resulting
from the significant correlation cluster (Fig. 1). The mean
values of rCBF in the pre-SMA in the pre- and post-
operative conditions at 5 and 42 months were 0.168±0.03,
0.234±0.03 and 0.258±0.03, respectively. The mean
improvements in rCBF from the pre- to the post-operative
conditions at 5 and 42 months (calculated as rCBF
medication off and stimulation on values at optimized
follow-up – rCBF medication off values at baseline/rCBF
medication off values at baseline × 100) were 39 and 53%,
respectively.
Statistical analysis
Data were obtained from all ten patients for the analysis at
5 and 42 months after DBS implants. As a first step, we
examined the predictive value of pre-operative parameters.
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They included: (1) pre-operative “medication off” rCBF
in the pre-SMA, (2) age at time of surgery, (3) pre-
operative UPDRS motor “medication on” scores, (4)
disease duration and (5) baseline percent improvement in
UPDRS motor scores using each patient’s typical doses
of levodopa. The post-operative outcome measures were
considered: (1) the response to stimulation evaluated by
UPDRS motor stimulation on/medication off scores at 5
and 42 months and (2) the percent improvement in motor
UPDRS scores from the pre- to the post-operative
conditions at 5 and 42 months, respectively. All pre-
operative factors potentially influencing post-operative
outcomes at 5 and 42 months after DBS were separately
explored by univariate analysis Pearson correlation test
and linear regression analyses. Then, a multivariate
model including all significant variables at univariate
analysis and using a forward stepwise procedure was
performed to identify which pre-operative factors could
effectively predict the post-operative outcome of patients
with PD treated with STN DBS.
As a second step, we investigated the mechanisms
underlying the predictive potential of pre-operative param-
eters. For this purpose, a univariate analysis Pearson
correlation test was used to evaluate the relationship within
all pre-operative data. Then, we investigated the relation-
ship within pre- and post-operative rCBF values and
between these values and percent improvements in rCBF
from the pre- to the post-operative conditions. Finally, we
examined if percent improvements in rCBF from the pre- to
the post-operative conditions were associated with both
percent improvements in UPDRS motor scores from the
pre- to the post-operative conditions and post-operative
UPDRS motor scores. The associations between post-
operative motor UPDRS scores and percent improvements
in UPDRS motor scores were also investigated. All
continuous variables were expressed as means ± SD or as
percent. A p value of 0.05 was considered significant.
Analyses were done using SPSS version 11.5 (SPSS Inc.,
Chicago, IL, USA).
Results
Predictive factors for bilateral STN stimulation at 5 months
after DBS implants
Results of the Pearson test showed that the pre-operative
rCBF values in the pre-SMA presented a negative correla-
tion with post-operative UPDRS motor scores (p=0.0001,
r=−0.981) (Fig. 2a) and a positive correlation with percent
improvement in UPDRS motor scores from the pre- to this
post-operative condition (p=0.0001, r=0.983) (Fig. 2b).
Among clinical variables, a positive correlation with post-
operative UPDRS motor scores and a negative correlation
with percent improvement in UPDRS were observed for
age (p=0.0001, r=0.96; p=0.0001, r=−0.92) (Fig. 2c, d),
pre-operative UPDRS motor scores (p=0.0001, r=0.944;
p=0.001, r=−0.889) and disease duration (p=0.01, r=
0.742; p=0.01, r=−0.759). The baseline percent improve-
ment in motor scores showed a negative correlation with
UPDRS motor scores (p=0.015, r=−0.739) and a positive
correlation with percent improvement in UPDRS motor
scores (p=0.009, r=0.774).
At univariate linear regression analysis, the pre-operative
rCBF in the pre-SMA was significantly associated with
both the post-operative UPDRS motor scores at 5 months
(R2=0.96, F=202, p=0.0001, β=−0.98) and percent motor
improvement from the pre- to the post-operative condition
(R2=0.96, F=222, p=0.0001, β=0.98). A significant
association with post-operative outcomes was also found
for age at time of surgery (R2=0.92, F=94, p=0.0001, β=
0.96; R2=0.84, F=44, p=0.0001, β=−0.92), pre-operative
UPDRS motor scores (R2=0.8, F=65, p=0.0001, β=0.94;
R2=0.8, F=30, p=0.001, β=−0.88), baseline percent
improvement in UPDRS motor scores (R2=0.546, F=9.6,
p=0.01, β=−0.739; R2=0.599, F=12, p=0.009, β=0.77)
and disease duration (R2=0.55, F=9.79, r=0.014, β=0.74;
R2=0.57, F=10, p=0.01, β=−0.75). In a multivariate
model including all the significant variables at univariate
analysis and using a forward stepwise procedure, we found
Fig. 1 rCBF increases in the right pre-SMA related to improvement
in motor function (motor UPDRS) from pre- to post-operative on-
stimulation conditions at 5 months and 4 years follow-up after the
application of VOI function in SPM, with a sphere (radius = 5 mm)
centred on peak voxel [peak z-score = 3.68 (p=0.0001 uncorrected);
location: x=6, y=4, z=62]
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that only the association of pre-operative rCBF in the pre-
SMA remained significant independently from post-
operative UPDRS motor scores and percent improvement
in UPDRS motor scores from the pre- to this post-operative
condition. If the pre-operative rCBF variable was excluded
from the model, we found that among all clinical variables
the age at time of surgery presented a significant associa-
tion with post-operative outcomes.
Predictive factors for bilateral STN stimulation
at 42 months after DBS implants
At univariate analysis Pearson test, the pre-operative rCBF
in the pre-SMA showed a negative correlation with post-
operative UPDRS motor scores at 42 months (p=0.0001,
r=−0.96) (Fig. 3a) and a positive correlation with percent
improvement in UPDRS motor scores from the pre- to the
post-operative condition at 42 months (p=0.0001, r=0.971)
(Fig. 3b). A positive correlation with post-operative
UPDRS motor score and a negative correlation with percent
improvement from the pre- to this post-operative condition
were observed for age at time of surgery (p=0.0001, r=
0.958; p=0.001, r=−0.924) (Fig. 3c, d), pre-operative
UPDRS motor scores (p=0.0001, r=0.954; p=0.0001,
r=−0.907) and disease duration (p=0.035, r=0.668; p=
0.02, r=−0.687). The baseline percent improvement in
UPDRS motor scores showed a negative correlation with
UPDRS motor scores at 42 months (p=0.0001, r=−0.965)
and a positive correlation with percent improvement in
UPDRS motor scores from the pre- to the post-operative
condition at 42 months (p=0.0001, r=0.931).
At univariate linear regression analysis, the pre-operative
rCBF in the pre-SMA was significantly associated with
UPDRS motor scores at 42 months (R2=0.92, F=97.27, p=
0.0001, β=−0.96) and percent motor improvement from
the pre- to the post-operative condition (R2=0.94, F=
132.324, p=0.0001, β=0.97). A relationship with both
post-operative outcomes was also present for age at time of
surgery (R2=0.9, F=90, p=0.0001, β=0.95; R2=0.85, F=
46.4, p=0.0001, β=−0.92), pre-operative UPDRS motor
Fig. 2 a rCBF increases in the
pre-SMA superimposed on a
normalized T1-weighted MRI
image and relationship between
rCBF values in this cortical area
for the pre-operative off drug
condition, as measured by the
VOI function in SPM, and indi-
vidual motor UPDRS scores for
the post-operative off drug/on
stimulation condition at
5 months. b Relationship
between rCBF values in the
pre-SMA for the pre-operative
off drug condition and percent
improvements in motor UPDRS
scores from the pre- to the post-
operative off drug/on stimula-
tion condition at 5 months. c
Relationship between age at
time of surgery and motor
UPDRS scores for the post-
operative off drug/on stimula-
tion condition at 5 months. d
Relationship between age at
time of surgery and percent
improvements in motor UPDRS
scores from the pre- to the post-
operative off drug/on stimula-
tion condition at 5 months.
Pre-SMA rostral part of the
supplementary motor area
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scores (R2=0.89, F=81.2, p=0.0001, β=−0.95; R2=0.82,
F=36.9, p=0.0991, β=−0.9), disease duration (R2=0.45,
F=6.46, p=0.035, β=0.67; R2=0.47, F=7.1, p=0.02,
β=−0.68) and baseline percent improvement (R2=0.642,
F=14, p=0.005, β=−0.801; R2=0.849, F=20, p=0.002,
β=0.849). In the multivariate model including all the
significant variables at univariate analysis, only the associ-
ation of pre-operative rCBF in the pre-SMA remained
significant independently from post-operative UPDRS
motor scores and percent improvement in UPDRS motor
scores from the pre- to this post-operative condition. If
the pre-operative rCBF variable was excluded from the
model, the age of patients at time of surgery and baseline
percent improvement in UPDRS motor score results were
significantly associated with post-operative outcomes.
Correlation within pre-operative variables
Results of the Pearson test showed that the pre-operative rCBF
in the pre-SMA presented a negative correlation with age at
time of surgery (p=0.0001, r=−0.937) (Fig. 4a), pre-
operative UPDRS motor scores (p=0.0001, r=−0.91)
(Fig. 4b) and disease duration (p=0.007, r=−0.787)
(Fig. 4c). A positive correlation was present between pre-
operative rCBF and baseline percent improvement in UPDRS
motor scores (p=0.008, r=0.777) (Fig. 4d). Among clinical
pre-operative variables, a significant positive correlation was
found between the age of patients at time of surgery and both
the pre-operative UPDRS motor scores (p=0.0001, r=0.988)
(Fig. 5a) and disease duration (p=0.03, r=0.683) (Fig. 5b).
A negative correlation was present between the age at time
of surgery and baseline percent improvement in UPDRS
motor scores (p=0.03, r=−0.679) (Fig. 5c).
Correlation between pre- and post-operative rCBF values,
percent improvement in rCBF, post-operative motor
UPDRS scores and percent improvement in motor UPDRS
Concerning the analysis of data at 42 months, we found that
the pre-operative rCBF in the pre-SMA was significantly
Fig. 3 a Relationship between
rCBF values in the pre-SMA for
the pre-operative off drug con-
dition and motor UPDRS scores
for the post-operative off drug/
on stimulation condition at
42 months. b Relationship be-
tween rCBF values in the pre-
SMA for the pre-operative off
drug condition and percent
improvements in motor UPDRS
scores from the pre- to the post-
operative off drug/on stimula-
tion condition at 42 months. c
Relationship between age at
time of surgery and motor
UPDRS scores for the post-
operative off drug/on stimula-
tion condition at 42 months. d
Relationship between age at
time of surgery and percent
improvements in UPDRS scores
from the pre- to the post-
operative off drug/on stimula-
tion condition at 42 months.
Pre-SMA rostral part of the
supplementary motor area
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associated with post-operative rCBF values at 42 months
(p=0.0001, r=0.964) (Fig. 6a). The pre- and post-operative
rCBF values in the pre-SMA at 42 months presented a
significant negative relationship with percent improvement
of rCBF in the pre-SMA from the pre- to the post-operative
condition at 42 months (p=0.0001, r=−0.928; p=0.003,
r=−0.829) (Fig. 6b, c), which also presented a significant
negative correlation with percent improvement in UPDRS
motor scores from the pre- to the post-operative condition
at 42 months (p=0.001, r=−0.869) (Fig. 6d) and a positive
correlation with post-operative UPDRS motor scores at
42 months (p=0.002, r=0.853) (Fig. 6e). A significant
negative relationship was found between the post-operative
UPDRS motor scores at 42 months and percent improve-
ment of UPDRS motor scores from the pre- to the post-
operative condition at 42 months (p=0.0001, r=−0.989)
(Fig. 6f).
Similarly, we found that the pre-operative rCBF in the
pre-SMA was significantly associated with post-operative
rCBF values at 5 months (p=0.001, r=0.868). A trend was
present toward a negative association between pre-operative
rCBF values and percent improvement of rCBF at 5 months
(p=0.05, r=−0.65). The percent improvement of rCBF in
the pre-SMA from the pre- to the post-operative condition
at 5 months presented a significant negative correlation
with percent improvement in UPDRS motor scores from
the pre- to this post-operative condition (p=0.02, r=−0.687)
and a trend toward a positive relationship with UPDRS
motor scores at 5 months (p=0.06, r=0.6). A significant
relationship was found between the post-operative UPDRS
motor scores at 5 months and percent improvement of rCBF
in the pre-SMA from the pre- to the post-operative condition
at 5 months (p=0.0001, r=−0.99).
Discussion
This study was undertaken to define predictive factors for
the outcome of treatment for PD by continuous bilateral
stimulation of the STN in order to identify characteristics of
the candidate who may receive the greatest benefit from
surgery. To address this issue we evaluated the predictive
Fig. 4 a Relationship between
pre-operative rCBF values in the
pre-SMA and age at time of
surgery. b Relationship between
rCBF values in the pre-SMA
and motor UPDRS scores for
the pre-operative off drug con-
dition. c Relationship between
rCBF values in the pre-SMA
and disease duration for the pre-
operative off drug condition. d
Relationship between rCBF val-
ues in the pre-SMA and percent
improvements in motor UPDRS
scores for the pre-operative off
drug condition. Pre-SMA rostral
part of the supplementary motor
area
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value of pre-operative rCBF in the pre-SMA and clinical
parameters including age at time of surgery, pre-operative
UPDRS motor medication on scores, disease duration and
baseline percent improvement in UPDRS motor scores. The
reason to investigate the potential for the rCBF in the pre-
SMA (Fig. 1) to predict patients’ outcome was supported
by the role of this cortical area in the recovery of motor
function during STN DBS [16–20]. In this group of ten
patients, who were rigorously selected and followed after
4 years of treatment, we found that the outcome of
neurosurgery at 5 and 42 months was markedly dependent
upon the pre-operative rCBF values in the pre-SMA and,
among clinical variables, the age and L-dopa response at
time of surgery. Indeed, results of uni- and multivariate
analyses clearly showed that parkinsonian patients present-
ing higher rCBF values and younger age at time of surgery
were characterized by higher UPDRS motor scores and
percent improvement of motor performance in the short- as
well in the long-term treatment with STN DBS. Results of
this study showed that also the L-dopa responsiveness was a
reliable predictor of favourable response for the long-term
outcome of treatment by STN DBS, e.g. the higher the
L-dopa responsiveness the higher the clinical benefit from
STN DBS at 4 years. Concerning the study of mechanisms
underlying the predictive potential, we found that patients
with higher rCBF values in the pre-SMA at time of surgery
were those with younger age, higher L-dopa responsiveness
and pre-operative motor performance, and shorter disease
duration. Interestingly, we also found that patients with
higher pre-operative rCBF values in the pre-SMA presented
with higher rCBF values at 42 months and that both these
parameters were negatively associated with percent
improvement in rCBF from the pre- to the post-operative
condition at 42 months. Besides, we found that the percent
improvement in rCBF in the pre-SMA from the pre- to the
post-operative condition at 42 months was negatively
associated with percent improvement in motor performance
and UPDRS motor scores at 42 months after surgery and
that these two parameters were negatively correlated.
Similar relationships were also found at 5 months after
DBS.
The most important finding of the current study was that
rCBF in the the pre-SMA is a key predictor of good
response to STN DBS. Importantly, since age strongly
Fig. 5 a Relationship between
age at time of surgery and pre-
operative motor UPDRS scale. b
Relationship between age and
disease duration at time of sur-
gery. c Relationship between
age at time of surgery and
baseline percent improvement in
motor UPDRS scores
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affects rCBF, the rCBF data of parkinsonian patients were
corrected for age to avoid the confounding effect of this
parameter. Although no study has been performed investi-
gating the influence of the brain on outcome of PD patients
treated with STN DBS, the superior motor response
observed in patients with higher pre-operative rCBF values
in the pre-SMA is consistent with the crucial role of this
high order motor cortical area in PD and STN DBS [16–
20]. Along with rCBF, the present results showed that age
and pre-operative L-dopa responsiveness are key predictors
of favourable outcome for STN DBS. This finding is
consistent with results of previous clinical studies obtained
in a larger series showing that PD patients with younger age
and better pre-operative response to medication tend to be
highly responsive to STN DBS [7–12]. Combined rCBF
and clinical factors suggest that PD patients with younger
Fig. 6 a Relationship between
rCBF values in the pre-SMA for
the pre-operative off drug con-
dition and for the post-operative
off drug/on stimulation condi-
tion at 42 months. b Relation-
ship between rCBF values in the
pre-SMA for the pre-operative
off drug condition and percent
improvements in rCBF in the
pre-SMA from the pre- to the
post-operative off drug/on stim-
ulation condition at 42 months.
c Relationship between rCBF
values in the pre-SMA for the
post-operative off drug/on stim-
ulation condition at 42 months
and percent improvements in
rCBF in the pre-SMA from the
pre- to the post-operative off
drug/on stimulation condition at
42 months. d Relationship
between percent improvements
in rCBF in the pre-SMA from
the pre- to the post-operative off
drug/on stimulation condition at
42 months and percent
improvements in motor UPDRS
scores for the pre-operative off
drug condition at 42 months. e
Relationship between percent
improvements in rCBF in the
pre-SMA from the pre- to the
post-operative off drug/on stim-
ulation condition at 42 months
and post-operative off drug/on
stimulation condition at
42 months. f Relationship
between percent improvements
in motor UPDRS scores for the
pre-operative off drug condition
at 42 months and post-operative
off drug/on stimulation condi-
tion at 42 months. Pre-SMA
rostral part of the supplementary
motor area
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age, higher L-dopa responsiveness and rCBF in the pre-
SMA have a better outcome for STN DBS, thus giving
further support to the evidence that this surgical therapy
could be considered early in the course of the disease [4–6].
Concerning the rationale for the predictive potential of
rCBF in the pre-SMA, results of correlation within pre-
operative variables suggest that the greater benefit from
STN DBS observed in PD patients with younger age
(Fig. 4a), higher motor scores at time of surgery (Fig. 4b),
shorter disease duration (Fig. 4c) and good response to
medication (Fig. 4d) is strictly related to a more preserved
function of the pre-SMA. Accordingly, results of correla-
tion between pre- and post-operative rCBF values, percent
improvement in rCBF, post-operative motor UPDRS
scores and percent improvement in motor UPDRS show
that in younger patients with high pre-operative rCBF
values in the pre-SMA small increases in rCBF due to
DBS are sufficient to reach high post-operative rCBF
values (Fig. 6a–c), which are related to both high
improvements in motor performance and UPDRS scores
in the years after surgery (Fig. 6d–f). On the contrary, in
older patients with low pre-operative rCBF values larger
increases in rCBF due to stimulation are necessary to
reach post-operative rCBF values that are lower than those
observed in younger patients with a better functioning pre-
SMA (Fig. 6a–c) and thus related to lower post-operative
improvement in motor performance and UPDRS scores
(Fig. 6d–f). Therefore, the STN DBS is likely to produce a
greater and faster clinical effect in younger parkinsonian
patients because it works on residual cortical neurons
whose function is relatively less compromised than that
observed in older PD patients. These findings are largely
supported by our understanding of current models of the
function of the basal ganglia motor circuit [25–27], the
pathological changes and the compensatory mechanisms
that progressively occur in PD [28–30], as well as the
neural mechanisms underlying the therapeutic effect of
STN DBS [19, 31–33]. Particularly, it is noteworthy that
younger PD patients are characterized by a more isolated
dopaminergic lesion and more effective compensatory
mechanisms and that both result in a better functioning
pre-SMA at the time of surgery [32, 34, 35]. Furthermore,
it is well known that success of a brain therapy generally
tends to correlate with degree of residual function within
surviving target neurons and that a normal function
demands that neurons work at a rather high capacity
which is more easily reached by such therapy if their
function is not completely compromised [36, 37].
Limitations of this study must be mentioned. Further
investigations with a larger series and with instrumentation
characterized by a higher spatial resolution are needed to
confirm the predictive potential of rCBF in the pre-SMA.
Although our clinical results are in line with those reported
by the majority of studies investigating the predictive
potential of pre-operative clinical parameters in PD patients
treated with STN DBS, there are at least two studies in
which the predictive role of age was not evident [13, 14].
Besides, prediction of greatest beneficial response to STN
DBS in younger patients has been observed mainly in the
short term and further studies are needed to confirm this
effect in the long term.
In summary, the present results assessed by means of
rCBF SPECT suggest that PD patients presenting at time of
surgery at a younger age and high L-dopa responsiveness
tend to have a favourable outcome after STN DBS because
of a better preserved function in the pre-SMA. This finding
may add further support to the evidence that neurosurgery
could be also considered earlier after the diagnosis of PD in
order to prevent psychological degradation and maintain
quality of life, especially in young patients facing a long
course of the disease. Furthermore, as previously proposed
[15], our findings also suggest that, along with clinical
measurements, the activity in cortical motor areas of crucial
importance in PD should be also taken into consideration as
a valuable marker of the candidates who may receive the
greatest benefit from surgery.
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